Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle

2 Aug 2021

Abstract excerpt

This article will review myogenic cell transplantation for congenital and acquired diseases of skeletal muscle. There are already a number of excellent reviews on this topic, but they are mostly focused on a specific disease, muscular dystrophies and in particular Duchenne Muscular Dystrophy. There are also recent reviews on cell transplantation for inflammatory myopathies, volumetric muscle loss (VML) (this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to Muscle Physiology and Disorders
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34408774
DOI: 10.3389/fgene.2021.702547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal MusclePMID 34408774Read ↗

Systemic cell therapy for muscular dystrophiesSemantic proximity Read ↗

Cell therapy for muscular dystrophiesSemantic proximity Read ↗

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an <i>in vitro</i> model and for therapy of muscular dystrophiesSemantic proximity Read ↗

Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patientsSemantic proximity Read ↗

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.Semantic proximity Read ↗

Molecular and cell-based therapies for muscle degenerations: a road under constructionSemantic proximity Read ↗

Current advances in cell therapy strategies for muscular dystrophiesSemantic proximity Read ↗

Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challengesSemantic proximity Read ↗

Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement TherapySemantic proximity Read ↗

Invited review: Stem cells and muscle diseases: advances in cell therapy strategiesSemantic proximity Read ↗

Advancements in stem cells treatment of skeletal muscle wastingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.